TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
about
HPV in exhaled breath condensate of lung cancer patientsGenetic susceptibility to lung cancer--light at the end of the tunnel?CIViC databaseIdentification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS).International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathwaysMDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European CaucasiansA field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian populationEffect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in SingaporeTP53 mutations in human cancers: origins, consequences, and clinical useClinical outcomes and correlates of TP53 mutations and cancer.Estimating the order of mutations during tumorigenesis from tumor genome sequencing data.p53 Pro72Arg polymorphism and prostate cancer in men of African descent.p53 codon 72 polymorphism and liver cancer susceptibility: a meta-analysis of epidemiologic studies.P53 codon 11, 72, and 248 gene polymorphisms in endometriosis.Evaluating the association between p53 codon 72 Arg>pro polymorphism and risk of ovary cancer: a meta-analysisAssociation between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis.Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controlsGenetic susceptibility to tobacco-related cancer.Gender specific association of TP53 polymorphisms (EX4 215G>C Arg72Pro, IVS3+40-41ins16, and IVS6+62G>A), with risk of oral cancer subtypes and overall survival of the patients.MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancerA meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects.p53 polymorphisms: cancer implications.Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibilityOCT1 and imatinib transport in CML: is it clinically relevant?Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy.Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma.Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature.TP53 p.R72P genotype is a marker of poor prognosis in lung cancer.Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population.Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.Association of p53 (-16ins-pro) haplotype with the decreased risk of differentiated thyroid carcinoma in Iranian-Azeri patients.Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.Impact of Violations and Deviations in Hardy-Weinberg Equilibrium on Postulated Gene-Disease Associations
P2860
Q24631711-1898E06B-CF3A-4DE4-96B1-2A526CF81CCAQ26852320-4DAF1FD5-ACF5-4213-8824-B05327802864Q27612411-B0F35C8F-A763-4376-9597-05D4C6ABFFD9Q30847332-98600772-CAB8-4CFF-B81B-A4E84E97B8EDQ30850865-3BB688C3-F6BA-4FD1-94D1-926754ECDE25Q33330490-321F49E1-CCA1-4F58-9B8F-203DD6DB5861Q33396628-3A74B1A4-D0F0-4899-A1C9-B929BEBA7AEBQ33441860-6B41FCD5-E9A3-42A3-8426-6F0BD4490DCEQ33539409-CFA0EE4C-D4F8-4C00-A915-451EADE600ECQ33685392-11E982BF-973F-444B-B57E-FE39836FC2C7Q33693838-E1468E53-088C-4096-AA17-ADD14CC8CF92Q34227940-10BE55DA-07E1-4B48-8E64-48C482D5B31BQ34670488-B508771A-4804-4992-84EF-9F480A53332BQ34717513-77419E74-1BF1-4C83-95F7-1CD0D1AE7CD1Q34885831-238141AE-0D71-402D-8B38-DFB71AEBE018Q35152940-CDD6DD3B-D6F3-49CB-AB55-52F2DB2326AFQ35195874-3986898B-B6F0-41E5-B75B-487E229B5AFEQ35578056-3ADFB3FC-FECD-441D-9FDC-8B7FA566D794Q35868053-09B16839-EA80-4F19-A855-445D5B538B7CQ36105663-1C1ED742-CE82-43C0-9709-DF285BD4DED9Q36787577-6F2D3F50-C266-40F8-BCA9-598A606BF011Q36911839-B366B281-2F78-4406-80E5-4471C4F436E0Q37073676-D1BD9014-82DA-4F1E-8C95-7345EA8E4FD9Q37376012-31041588-9AD2-4277-9F57-D84F3B9C802CQ37589252-E023CEAA-1939-4794-8E71-E9AA79F0999FQ38540022-DEC4B91E-0AB1-45A5-8C25-C23D134A3961Q43509391-AB2839E9-A135-43C2-B015-E37BCB7798CCQ43579146-714010CB-09BB-4ADD-9253-24DCD530F2A2Q44955068-D8B3288B-FC7D-429C-9938-C99F5E2D019CQ45396018-F6D5E7BC-0426-4055-9563-E4182060F4A7Q46307849-7BA7BE51-72F9-4BBA-9D02-AD9F5739AB8AQ49494194-61F9CD29-E633-4024-B117-173842CAD9E0Q53247820-A6678AF8-AE7B-430E-9C77-A3703FE7F800Q54198614-C1B58E09-E761-459D-9EE3-270099F962B1Q54322019-AC92932B-B3D5-4EB4-919C-4E6F387DEEAAQ54542826-1EE8BFA3-1147-4B8D-BD47-EABF1A2B5922Q57542910-6897BD9D-1E59-4301-B672-70D6775407B8
P2860
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
@ast
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
@en
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
@nl
type
label
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
@ast
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
@en
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
@nl
prefLabel
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
@ast
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
@en
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
@nl
P2093
P31
P356
P1433
P1476
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
@en
P2093
A Matakidou
R S Houlston
P304
P356
10.1093/MUTAGE/GEG008
P577
2003-07-01T00:00:00Z